We're sorry, in order to view this member's profile you must be a member. Please login, or apply for membership. If you're currently a member with us, but this is your first time logging in a while, your password may have changed for security reasons. In order to access the registry, please reset your password, or contact us today.
Education, Honors & Awards
Post Doctorate Degree in Physiopathology of the Limbic System from Shiga University of Medical Science, Japan (1983); PhD in Neurophysiology from the University from the University of Bordeaux (1987)
Brigitte Onteniente speaks publicly about her company, Phenocell, their purpose, stem sells, and drug discovery. Dr. Onteniente's work has been published in several journals. She built and coordinated the STEMS European project after a sabbatical year in Southampton University. She is fuent in French and English. Phenocell aims at accelerating the development of innovative therapies for rare diseases. With the unique technology of cell reprogramming, the company creates, produces and commercializes unique cellular models for orphan drug discovery. We develop specific phenotype assays for the understanding of pathogenic mechanisms, drug discovery and ADME-T studies. Phenocell's iPSC and differentiated cellular models are designed to perfectly fit with the requirements of academic and industrial research.